Page last updated: 2024-11-13

doxycycline hyclate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Tetraclean: antibiotic-based product for root canal irrigation to remove both the microorganisms and the smear layer present in the root canals; contains cetrimide (Cetrimonium Compounds) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID54686183
CHEMBL ID3989740
MeSH IDM0104501

Synonyms (87)

Synonym
vibravenos
tetradox
azudoxat
spanor
retens
mespafin
ronaxan
lymepak (tn)
doxy
periostat (tn)
vibra-tabs (tn)
D02129
doryx (tn)
doxycycline hydrochloride hydrate (jp17)
doxycycline hyclate (usp)
doxy 100
atridox
doxy-lemmon
6-deoxy-5-hydroxytetracycline hydrochloride hemihydrate
doxy 200
vivox
vibra-tabs
periostat
4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, compound with ethyl alcohol (2:1), monohydrate
doryx
doxychel hyclate
doxycycline hyclate (internal use)
(4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide - ethanol (2:1) dihydrochloride hydrate
AC-6017
nsc-741421
S4163
nsc 741421
doryx mpc
tetraclean
dentista
doxycycline hyclate [usan:usp]
unii-19xts3t51u
acticlate
wc 2031
19xts3t51u ,
doxteric
acticlate cap
monodoks
doxyprex
doxycycline hyclate [ep impurity]
doxycyclini hyclas [who-ip latin]
doxycycline hyclate [ep monograph]
lymepak
doxycycline hyclate [usp-rs]
doxycycline hydrochloride hemiethanolate hemihydrate [mi]
doxycycline hyclate [usp monograph]
unacil
doxycycline hyclate [who-ip]
vibraveineuse
doxycycline hyclate [vandf]
doxicrisol
duradoxal
doxycycline hydrochloride hydrate [jan]
zadorin
doxylar
granudoxy
doxycycline hyclate [who-dd]
doxycycline hyclate [orange book]
doxycycline hyclate [green book]
diocimex
clinofug
AKOS025402170
(4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride
wc2031
EN300-379220
bis((4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide) ethanol hydrate dihydrochloride
Z2791720087
(4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide compound with ethanol (2:1) dihydrochloride hydrate
CHEMBL3989740
doxycyclini hyclas
doxycycline hydrochloride hydrate
SW219440-2
SW219440-1
DS-9077
doxycycline, hyclate - cas 24390-14-5
Q27116248
doxycycline hyclate 100 microg/ml in acetonitrile
AMY32700
CCG-270611
doxycycline hyclate is known as a broad-spectrum tetracycline antibiotic.
BD166236
AKOS040742632
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (100.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 126.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index126.79 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index232.68 (26.88)
Search Engine Supply Index2.04 (0.95)

This Compound (126.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (25.00%)5.53%
Reviews2 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (58.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]